Conformational studies of novel antiretroviral analogs of zidovudine. 2003

Maria T Baumgartner, and Marisa I Motura, and Rubén H Contreras, and Adriana B Pierini, and Margarita C Briñón
Departamento de Química Organica-INFIQC, Ciudad Universitaria, Universidad Nacional de Córdoba, Córdoba, Argentina.

Conformational properties of three novel zidovudine analogs, namely 3'-azido-3'-deoxy-5'-O-isonicotinoylthymidine (AZT-Iso, 2), (-)-trans-(5S,6S)-5-bromo-6, 5'-epoxy-5,6-dihydro-3'-azido-3'-deoxythymidine (3) and (+)-trans-(5R,6R)-5-bromo-6,5'-epoxy-5,6-dihydro-3'-azido-3'-deoxythymidine (4), have been investigated by AM1 calculations and NMR studies, and compared with those of the parent nucleoside (AZT, 1). Based on the results obtained the following correlation may be established, a) AZT and AZT-Iso exhibit a conformational behavior analog to other pyrimidinic nucleosides, displaying a dynamic equilibrium in solution where the two conformers (North and South) undergo a constant transformation. b) Compounds 3 and 4 show a different conformational profile. The estimate of the pseudorotation phase angle reveals the rigid structures of the latter compounds, which do not evidence conformational equilibrium in solution; the azide group being the only group free to rotate. c) Diastereoisomers 3 and 4 exhibit an extra conformational parameter compared with other pyrimidinic nucleosides: the chair or boat conformation in the third ring formed between the sugar and the base. In all cases, a reasonable correlation was obtained between theoretical and NMR spectroscopic data.

UI MeSH Term Description Entries
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D044966 Anti-Retroviral Agents Agents used to treat RETROVIRIDAE INFECTIONS. Antiretroviral Agent,Antiretroviral Agents,Agent, Antiretroviral,Agents, Anti-Retroviral,Agents, Antiretroviral,Anti Retroviral Agents

Related Publications

Maria T Baumgartner, and Marisa I Motura, and Rubén H Contreras, and Adriana B Pierini, and Margarita C Briñón
June 2016, Bioorganic chemistry,
Maria T Baumgartner, and Marisa I Motura, and Rubén H Contreras, and Adriana B Pierini, and Margarita C Briñón
January 2006, Nucleosides, nucleotides & nucleic acids,
Maria T Baumgartner, and Marisa I Motura, and Rubén H Contreras, and Adriana B Pierini, and Margarita C Briñón
January 1989, AIDS (London, England),
Maria T Baumgartner, and Marisa I Motura, and Rubén H Contreras, and Adriana B Pierini, and Margarita C Briñón
January 1994, Molecular pharmacology,
Maria T Baumgartner, and Marisa I Motura, and Rubén H Contreras, and Adriana B Pierini, and Margarita C Briñón
September 1987, International journal of peptide and protein research,
Maria T Baumgartner, and Marisa I Motura, and Rubén H Contreras, and Adriana B Pierini, and Margarita C Briñón
January 1989, AIDS (London, England),
Maria T Baumgartner, and Marisa I Motura, and Rubén H Contreras, and Adriana B Pierini, and Margarita C Briñón
February 1985, Indian journal of biochemistry & biophysics,
Maria T Baumgartner, and Marisa I Motura, and Rubén H Contreras, and Adriana B Pierini, and Margarita C Briñón
February 1998, Biochemical Society transactions,
Maria T Baumgartner, and Marisa I Motura, and Rubén H Contreras, and Adriana B Pierini, and Margarita C Briñón
October 2002, International journal of antimicrobial agents,
Maria T Baumgartner, and Marisa I Motura, and Rubén H Contreras, and Adriana B Pierini, and Margarita C Briñón
October 2003, HIV medicine,
Copied contents to your clipboard!